In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

Q1 2025 Earnings Call Transcript May 9, 2025 Ultralife Corporation misses on earnings expectations. Reported EPS is $0.13 EPS ...

The Trade-Adverse Trade Adviser: Once sidelined, President Trump’s counselor Peter Navarro has returned to Washington and ...